To design and implement integrated strategies, linking appropriate chromatography and mass spectrometry tools, to perform a qualitative and quantitative assessment of product related variants and impurities.
M.Pharm with 15 to 20 years of experience in Formulation development of sterile, non-sterile Dosage forms as per guidelines of US, EU, Canada, Brazil and ROW market. Literature search, Pre - formulation and compatibility studies,formulation & development as per QbD, Scale-up and Technology transfer.
Master Degree or PG Diploma in Life Sciences or Biomedical Sciences or Pharmacy or Public Health or Clinical Research.
at least 4 years of demonstrated experience in clinical trial monitoring or clinical site management experience.
Doctoral Degree in Science from a recognised university or equivalent in stem cell biology, developmental biology, pharmacology, and or maternal or child health.
The candidate must have a M.S, M.Pharm, degree in Medicinal chemistry, Natural Products, Pharmaceutical Analysis from a PCI, AICTE, UGC, NAAC recognized, accredited University, Central Autonomous Institutes with 60% marks or above.
M.D Pharmacology M.V.Sc. Pharmacology M.Pharma, M.Sc. Medicinal Plants with specialization in Pharmacology from a recognized University Institution. Post Graduate degree in the Chemistry from a recognized University, Institution.
A Masters M.Pharm or M.Sc. or M.Tech. or M.E. or Bachelors B.Tech or B.E. or B.Pharm. An understanding of the Process Development and Industrial perspective of Biotherapeutics/ Biosimilars. Basic understanding of analytical techniques, statistical analysis, data management and analysis.